26 February 2021
4basebio UK
Societas
(the "Company")
Director’s
Dealing
4basebio UK Societas (AIM: 4BB), the specialist life sciences
group focused on exploiting its intellectual property in the field
of gene therapies and DNA vaccines, announces that, on 25 February 2021, Heikki
Lanckriet, chief executive officer, acquired 3,000 ordinary
shares at an average price of 345
pence per share on behalf of persons closely associated with
him.
As a result of the acquisition of ordinary shares, Heikki
Lanckriet’s beneficial holding, including shares held by persons
closely associated with him, comprises 1,240,003 ordinary shares
representing 10.07 per cent. of the Company’s issued share
capital.
This announcement contains inside information for the purposes
of Article 7 of EU Regulation 596/2014.
For further enquiries, please
contact:
4basebio UK
Societas
Heikki Lanckriet |
+44 (0)1223 967
943 |
|
|
Nominated
Adviser
Cairn Financial Advisers LLP
Jo Tuner / Sandy Jamieson |
+44 (0)20 7213
0880
|
|
|
Broker
finnCap Ltd
Geoff Nash/Richard Chambers/Charlotte Sutcliffe |
+44 (0)20 7220
0500 |
Notification and public disclosure of
transactions by persons discharging managerial responsibilities and
persons closely associated with them
|
Notification of a Transaction pursuant to Article 19(1) of
Regulation (EU) No. 596/2014 |
| 1 |
Details
of the person discharging managerial responsibilities/person
closely associated |
| a. |
Name |
Heikki
Lanckriet |
| 2 |
Reason for
notification |
|
| a. |
Position/Status |
Chief Executive Officer |
| b. |
Initial
notification/
Amendment |
Initial |
| 3 |
Details
of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor |
| a. |
Name |
4basebio
UK Societas |
| b. |
LEI |
2138005D5SAG8FIR6G91 |
| 4 |
Details
of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and
(iv) each place where transactions have been conducted |
| a. |
Description of the
financial instrument, type of instrument
Identification Code |
Ordinary Shares
ISIN: GB00BLD8ZL39 |
| b. |
Nature of the
transaction |
Acquisition of ordinary shares |
| c. |
Price(s)
and volume(s) |
|
|
|
|
|
|
Volume(s) |
Price (p) |
|
- 1,000
- 1,000
- 1,000
|
345p
345p
345p |
|
|
| d. |
Aggregated information
- Aggregated Volume
- Price |
-3,000
-345 pence per share |
| e. |
Date of the
transaction |
25/2/2021 |
| f. |
Place of the
transaction |
London
Stock Exchange, AIM |
|
|
|
|
|
|
|
|
|